Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Duodenum | 1 | 2024 | 41 | 0.860 |
Why?
|
| Abdominal Injuries | 1 | 2024 | 32 | 0.840 |
Why?
|
| Tissue Engineering | 6 | 2017 | 148 | 0.800 |
Why?
|
| Crisis Intervention | 1 | 2021 | 27 | 0.680 |
Why?
|
| Blood Vessel Prosthesis | 7 | 2017 | 214 | 0.650 |
Why?
|
| Thoracostomy | 1 | 2020 | 8 | 0.630 |
Why?
|
| Pleurodesis | 1 | 2020 | 9 | 0.630 |
Why?
|
| Pneumothorax | 1 | 2020 | 49 | 0.610 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2020 | 62 | 0.600 |
Why?
|
| Child | 17 | 2025 | 4612 | 0.570 |
Why?
|
| Inpatients | 1 | 2021 | 318 | 0.570 |
Why?
|
| Hospitalization | 9 | 2024 | 1392 | 0.520 |
Why?
|
| Adolescent | 14 | 2025 | 6305 | 0.470 |
Why?
|
| Venous Thromboembolism | 3 | 2023 | 150 | 0.460 |
Why?
|
| Bariatric Surgery | 2 | 2025 | 65 | 0.410 |
Why?
|
| Cross-Sectional Studies | 10 | 2024 | 2703 | 0.410 |
Why?
|
| Pediatric Obesity | 2 | 2025 | 129 | 0.380 |
Why?
|
| Blood Vessels | 1 | 2012 | 63 | 0.360 |
Why?
|
| Craniocerebral Trauma | 3 | 2020 | 53 | 0.330 |
Why?
|
| Infant | 7 | 2024 | 1693 | 0.320 |
Why?
|
| Wounds and Injuries | 2 | 2023 | 250 | 0.300 |
Why?
|
| Skiing | 2 | 2020 | 8 | 0.300 |
Why?
|
| Specialties, Surgical | 2 | 2020 | 46 | 0.290 |
Why?
|
| Tissue Scaffolds | 6 | 2017 | 90 | 0.280 |
Why?
|
| Athletic Injuries | 2 | 2020 | 82 | 0.280 |
Why?
|
| Crohn Disease | 2 | 2020 | 107 | 0.280 |
Why?
|
| Firearms | 2 | 2019 | 63 | 0.280 |
Why?
|
| Female | 21 | 2025 | 34016 | 0.260 |
Why?
|
| Male | 18 | 2025 | 31042 | 0.260 |
Why?
|
| Databases, Factual | 4 | 2024 | 882 | 0.260 |
Why?
|
| Child, Preschool | 5 | 2024 | 2061 | 0.250 |
Why?
|
| Injury Severity Score | 2 | 2024 | 117 | 0.240 |
Why?
|
| Models, Animal | 3 | 2017 | 241 | 0.240 |
Why?
|
| United States | 10 | 2025 | 8097 | 0.240 |
Why?
|
| Retrospective Studies | 9 | 2024 | 6862 | 0.230 |
Why?
|
| Portal Vein | 2 | 2017 | 39 | 0.230 |
Why?
|
| Humans | 27 | 2025 | 65124 | 0.230 |
Why?
|
| Length of Stay | 3 | 2024 | 827 | 0.220 |
Why?
|
| Cultural Diversity | 1 | 2025 | 54 | 0.210 |
Why?
|
| Accidents, Traffic | 1 | 2024 | 140 | 0.200 |
Why?
|
| Career Choice | 1 | 2025 | 126 | 0.200 |
Why?
|
| Obesity, Morbid | 1 | 2024 | 93 | 0.200 |
Why?
|
| Minority Groups | 1 | 2025 | 141 | 0.200 |
Why?
|
| Comorbidity | 3 | 2020 | 1119 | 0.180 |
Why?
|
| Wounds, Gunshot | 2 | 2019 | 48 | 0.180 |
Why?
|
| General Surgery | 1 | 2025 | 211 | 0.180 |
Why?
|
| Head Protective Devices | 2 | 2020 | 18 | 0.180 |
Why?
|
| Snow Sports | 1 | 2020 | 2 | 0.160 |
Why?
|
| Surgeons | 2 | 2020 | 191 | 0.160 |
Why?
|
| Healthcare Disparities | 1 | 2025 | 407 | 0.160 |
Why?
|
| Cerebral Intraventricular Hemorrhage | 1 | 2020 | 8 | 0.160 |
Why?
|
| Young Adult | 5 | 2025 | 4810 | 0.160 |
Why?
|
| Infant Mortality | 1 | 2020 | 20 | 0.160 |
Why?
|
| Chest Tubes | 1 | 2020 | 16 | 0.160 |
Why?
|
| Sex Factors | 2 | 2020 | 991 | 0.160 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2020 | 13 | 0.160 |
Why?
|
| Deficiency Diseases | 1 | 2019 | 12 | 0.150 |
Why?
|
| Play and Playthings | 1 | 2019 | 19 | 0.150 |
Why?
|
| Bites and Stings | 1 | 2019 | 10 | 0.150 |
Why?
|
| Accidental Falls | 1 | 2020 | 128 | 0.150 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2019 | 17 | 0.150 |
Why?
|
| Age Factors | 2 | 2021 | 1585 | 0.150 |
Why?
|
| Social Class | 1 | 2020 | 137 | 0.150 |
Why?
|
| Patient Compliance | 1 | 2021 | 364 | 0.150 |
Why?
|
| Infant, Premature, Diseases | 1 | 2019 | 49 | 0.150 |
Why?
|
| Respiratory System Abnormalities | 1 | 2018 | 3 | 0.150 |
Why?
|
| Infant, Newborn | 5 | 2020 | 1421 | 0.140 |
Why?
|
| Dogs | 1 | 2019 | 315 | 0.140 |
Why?
|
| Referral and Consultation | 1 | 2021 | 440 | 0.130 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2019 | 110 | 0.130 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2018 | 99 | 0.130 |
Why?
|
| Suicide | 1 | 2019 | 146 | 0.130 |
Why?
|
| Lung Diseases | 1 | 2018 | 183 | 0.130 |
Why?
|
| Radiography | 1 | 2018 | 555 | 0.120 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2020 | 268 | 0.120 |
Why?
|
| Risk Factors | 6 | 2023 | 5429 | 0.120 |
Why?
|
| Mass Screening | 1 | 2021 | 698 | 0.120 |
Why?
|
| Dioxoles | 1 | 2015 | 2 | 0.110 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2015 | 30 | 0.110 |
Why?
|
| Nanofibers | 1 | 2015 | 20 | 0.110 |
Why?
|
| Benzamides | 1 | 2015 | 69 | 0.110 |
Why?
|
| Constriction, Pathologic | 1 | 2015 | 130 | 0.110 |
Why?
|
| Neurons | 3 | 2004 | 933 | 0.110 |
Why?
|
| Receptors, Nicotinic | 2 | 2004 | 69 | 0.110 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 497 | 0.100 |
Why?
|
| Nanotechnology | 1 | 2015 | 139 | 0.100 |
Why?
|
| Mesenteric Veins | 1 | 2013 | 11 | 0.100 |
Why?
|
| Hippocampus | 2 | 2004 | 276 | 0.090 |
Why?
|
| Catheterization, Central Venous | 1 | 2013 | 84 | 0.090 |
Why?
|
| Animals | 11 | 2019 | 21324 | 0.090 |
Why?
|
| Nanomedicine | 1 | 2012 | 24 | 0.090 |
Why?
|
| Venous Thrombosis | 1 | 2013 | 112 | 0.090 |
Why?
|
| Fibrinolytic Agents | 1 | 2013 | 178 | 0.090 |
Why?
|
| Thrombolytic Therapy | 1 | 2013 | 195 | 0.090 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 237 | 0.090 |
Why?
|
| Biocompatible Materials | 1 | 2012 | 154 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2018 | 805 | 0.080 |
Why?
|
| ROC Curve | 2 | 2021 | 292 | 0.070 |
Why?
|
| Infant, Premature | 2 | 2020 | 198 | 0.070 |
Why?
|
| Multivariate Analysis | 2 | 2020 | 930 | 0.060 |
Why?
|
| Registries | 2 | 2021 | 922 | 0.060 |
Why?
|
| Mice | 7 | 2017 | 11105 | 0.060 |
Why?
|
| Logistic Models | 2 | 2019 | 1270 | 0.060 |
Why?
|
| Amitriptyline | 1 | 2004 | 7 | 0.060 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2004 | 19 | 0.050 |
Why?
|
| Intermediate Filament Proteins | 1 | 2004 | 19 | 0.050 |
Why?
|
| Olfactory Bulb | 1 | 2004 | 19 | 0.050 |
Why?
|
| Needs Assessment | 1 | 2025 | 201 | 0.050 |
Why?
|
| Transgenes | 1 | 2004 | 204 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 863 | 0.050 |
Why?
|
| Behavior, Animal | 1 | 2004 | 234 | 0.050 |
Why?
|
| Stem Cells | 1 | 2004 | 276 | 0.050 |
Why?
|
| Trauma Centers | 1 | 2023 | 130 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 428 | 0.040 |
Why?
|
| Glasgow Coma Scale | 1 | 2021 | 48 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 687 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2025 | 1015 | 0.040 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2021 | 59 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2024 | 897 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2004 | 1036 | 0.040 |
Why?
|
| Perioperative Period | 1 | 2020 | 20 | 0.040 |
Why?
|
| North America | 1 | 2020 | 114 | 0.040 |
Why?
|
| Ligation | 1 | 2020 | 37 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 169 | 0.040 |
Why?
|
| Infant, Low Birth Weight | 1 | 2020 | 59 | 0.040 |
Why?
|
| Contusions | 1 | 2019 | 10 | 0.040 |
Why?
|
| Neonatologists | 1 | 2019 | 1 | 0.040 |
Why?
|
| Torso | 1 | 2019 | 21 | 0.040 |
Why?
|
| Patient Admission | 1 | 2021 | 198 | 0.040 |
Why?
|
| Intestinal Obstruction | 1 | 2020 | 51 | 0.040 |
Why?
|
| Eye Injuries | 1 | 2019 | 13 | 0.040 |
Why?
|
| Neck Injuries | 1 | 2019 | 18 | 0.040 |
Why?
|
| Income | 1 | 2020 | 169 | 0.040 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 105 | 0.040 |
Why?
|
| Laparotomy | 1 | 2019 | 54 | 0.040 |
Why?
|
| Incidence | 1 | 2023 | 1418 | 0.040 |
Why?
|
| Hospital Costs | 1 | 2019 | 126 | 0.040 |
Why?
|
| X-Rays | 1 | 2018 | 46 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 372 | 0.040 |
Why?
|
| Chi-Square Distribution | 1 | 2019 | 414 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2023 | 525 | 0.040 |
Why?
|
| Adult | 3 | 2025 | 17356 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 1113 | 0.040 |
Why?
|
| Suicide, Attempted | 1 | 2019 | 111 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 2019 | 288 | 0.030 |
Why?
|
| Urban Population | 1 | 2019 | 200 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2021 | 420 | 0.030 |
Why?
|
| Leadership | 1 | 2020 | 211 | 0.030 |
Why?
|
| Gestational Age | 1 | 2018 | 192 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2017 | 27 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2015 | 3478 | 0.030 |
Why?
|
| Rural Population | 1 | 2019 | 223 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2019 | 489 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2017 | 518 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2015 | 1656 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2020 | 875 | 0.030 |
Why?
|
| Implants, Experimental | 1 | 2015 | 5 | 0.030 |
Why?
|
| Polyglycolic Acid | 1 | 2015 | 18 | 0.030 |
Why?
|
| Reference Standards | 1 | 2015 | 76 | 0.030 |
Why?
|
| Polyesters | 1 | 2015 | 45 | 0.030 |
Why?
|
| Critical Care | 1 | 2018 | 402 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2015 | 75 | 0.030 |
Why?
|
| Sheep | 1 | 2015 | 189 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2015 | 113 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2102 | 0.030 |
Why?
|
| Aorta | 1 | 2015 | 108 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2015 | 178 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 706 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2015 | 148 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2015 | 576 | 0.030 |
Why?
|
| Lung | 1 | 2018 | 962 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2013 | 175 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 2763 | 0.020 |
Why?
|
| Massachusetts | 1 | 2018 | 2145 | 0.020 |
Why?
|
| Polymers | 1 | 2015 | 332 | 0.020 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2011 | 60 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2004 | 2155 | 0.020 |
Why?
|
| Macrophages | 1 | 2015 | 1037 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2020 | 5788 | 0.020 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2011 | 276 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 2483 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 3762 | 0.020 |
Why?
|
| Helplessness, Learned | 1 | 2004 | 2 | 0.010 |
Why?
|
| Nortriptyline | 1 | 2004 | 3 | 0.010 |
Why?
|
| Hindlimb Suspension | 1 | 2004 | 3 | 0.010 |
Why?
|
| Gliosis | 1 | 2004 | 27 | 0.010 |
Why?
|
| Mecamylamine | 1 | 2004 | 14 | 0.010 |
Why?
|
| Nicotinic Antagonists | 1 | 2004 | 19 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2004 | 44 | 0.010 |
Why?
|
| Nestin | 1 | 2004 | 13 | 0.010 |
Why?
|
| Swimming | 1 | 2004 | 30 | 0.010 |
Why?
|
| Cell Count | 1 | 2004 | 128 | 0.010 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2004 | 45 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2004 | 124 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 602 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 449 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 856 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 896 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 1287 | 0.010 |
Why?
|
| Apoptosis | 1 | 2004 | 1100 | 0.010 |
Why?
|
| Aging | 1 | 2004 | 771 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2004 | 758 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2004 | 1630 | 0.010 |
Why?
|